STEPHEN N. KEITH

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Nuo Therapeutics, Inc.

Filing Date Source Excerpt
2009-08-11 Dr. Keith holds an undergraduate degree magna cum laude from Amherst College, a degree in medicine from University of Illinois, College of Medicine, and a Master of Science in Public Health degree from the University of California, Los Angeles.
2010-05-27 Stephen N. Keith
2010-08-25 Dr. Keith holds an undergraduate degree magna cum laude from Amherst College, a degree in medicine from University of Illinois, College of Medicine, and a Master of Science in Public Health degree from the University of California, Los Angeles.
2011-08-22 Dr. Keith holds an undergraduate degree magna cum laude from Amherst College, a degree in medicine from University of Illinois, College of Medicine, and a Master of Science in Public Health degree from the University of California, Los Angeles.
2012-04-16 Stephen N. Keith - Independent director of the Company. Includes 136,667 shares Dr. Keith may acquire upon the exercise of stock options approved by the Board and issued under the Company’s Long-Term Incentive Plan.
2012-08-20 Dr. Keith holds an undergraduate degree from Amherst College, a degree in medicine from University of Illinois, College of Medicine, and a Master of Science in Public Health degree from UCLA. He is a licensed physician.
2013-04-26 Stephen N. Keith - Independent director of the Company. Includes176,667 shares Dr. Keith may acquire upon the exercise of stock options approved by the Board and issued under the Company’s Long-Term Incentive Plan.
2013-11-12 Stephen N. Keith, MD, MSPH has served as a Director since September 19, 2008. Dr. Keith served as the Chief Executive Officer of the American College of Clinical Pharmacology... He received the M.D. degree from the University of Illinois in 1977... He received a Masters in Science in Public Health from UCLA.
2014-05-02 Stephen N. Keith - Independent director of the Company. Includes 216,665 shares Dr. Keith may acquire upon the exercise of stock options approved by the Board and issued under the Company’s 2002 Long-Term Incentive Plan and 2013 Equity Incentive Plan.
2014-10-01 Dr. Keith completed his undergraduate work at Amherst College, received the M.D. degree from the University of Illinois, and a Masters in Science in Public Health from UCLA. His career is in clinical pharmacology and healthcare.

Data sourced from SEC filings. Last updated: 2026-02-03